Cargando…
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
BACKGROUND: Immunohistochemical markers are often used to classify breast cancer into subtypes that are biologically distinct and behave differently. The aim of this study was to estimate mortality for patients with the major subtypes of breast cancer as classified using five immunohistochemical mar...
Ejemplares similares
-
Authors’ response to Li et al. Obes Facts 2015;8:DOI: 10.159/000381434
por: Sichieri, Rosely, et al.
Publicado: (2015) -
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010) -
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010) -
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis
por: Sobral-Leite, Marcelo, et al.
Publicado: (2015) -
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
por: Tischkowitz, Marc, et al.
Publicado: (2007)